Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin.
about
Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.What's new in lipid management?Role of the pharmacist in establishing lipid intervention programs.Efficacy and safety of a generic rosuvastatin in a real-world setting: prospective, observational clinical study in Lebanese patients.
P2860
Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@ast
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@en
type
label
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@ast
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@en
prefLabel
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@ast
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@en
P1476
Statin therapy and reductions ...... otent new statin Rosuvastatin.
@en
P2093
P304
P356
10.1016/S0002-9149(01)01455-2
P407
P577
2001-03-01T00:00:00Z